Associate Professor and Director of Research
University of Texas Health Science Center at Houston
Simon Young, DDS, MD, PhD, is Assistant Professor and Director of Research in the Department of Oral and Maxillofacial Surgery, University of Texas Health Science Center at Houston, School of Dentistry, Houston, Texas. He completed his DDS at the Faculty of Dentistry, University of Toronto, in 2003, his PhD at Rice University, Department of Bioengineering, Houston, Texas, in 2008, and his MD at University of Texas Medical School at Houston in 2011. He subsequently completed first an Oral & Maxillofacial Surgery Residency at University of Texas Health Science Center at Houston and then a Postdoctoral Research Fellowship in Immuno-Engineering at Harvard University, School of Engineering and Applied Sciences. Dr. Young is a Diplomate of the American Board of Oral and Maxillofacial Surgery. He is the author of more than 35 articles in peer-reviewed journals.
Dr. Simon Young’s research efforts include the synthesis and characterization of implantable biomaterials designed to elicit in situ cell recruitment and programming. His work includes the use of materials able to simultaneously deliver multiple bioactive factors with distinct release profiles. These constructs have been used in a diverse set of applications such as the promotion of craniofacial bone regeneration and cancer immunotherapy. He has broad experience in the fields of polymer synthesis and characterization, growth factor delivery, in vivo models, characterization of bone and neovascularization, cancer immunotherapy, and implantable therapeutic cancer vaccines.
The focus of his current research is to develop novel material-based immunotherapies for the treatment of head and neck cancer and explore mechanisms of how this approach may synergize with other modalities of treatment, such as chemo/radiation therapy. The paradigm of in situ cell programming using biomaterials is also being utilized in separate research projects in collaboration with MIT and Rice University, exploring the use of layer-by-layer technology to deliver bioactive factors for the enhancement of craniofacial bone regeneration and Multidomain Peptides for nerve regeneration.
Disclosure: KLS Martin (Individual(s) Involved: Self): Research Grant; Privo Technologies (Individual(s) Involved: Self): Research Grant; Proteocyte Diagnostics (Individual(s) Involved: Self): Consultant/Advisory Board
Friday, October 1, 2021
1:50 PM – 2:10 PM CDT
Friday, October 1, 2021
2:50 PM – 3:00 PM CDT
On-demand